Guardant nabs chief commercial officer from Gilead as it preps more 'liquid biopsy' rollouts

Byline: Beth Snyder Bulik From Gilead to Guardant isn't much of a leap in the alphabet, but it's a big jump in the pharma industry for Chris Freeman. Freeman, who [...]